Click here to get full coverage on REGENXBIO Announces Presentation at the World Muscle Society - PR Newswire

REGENXBIO Announces Presentation at the World Muscle Society  PR Newswire

REGENXBIO Announces Presentation at the World Muscle Society - PR Newswire

Click here to get full coverage on What dividend safety score for RGNX stock - New Guidance & Consistent Income Trade Recommendations - Fundação Cultural do Pará

What dividend safety score for RGNX stock - New Guidance & Consistent Income Trade Recommendations  Fundação Cultural do Pará

What dividend safety score for RGNX stock - New Guidance & Consistent Income Trade Recommendations - Fundação Cultural do Pará

Click here to get full coverage on RGNX stock outlook for YEAR - Inflation Watch & Real-Time Price Movement Reports - newser.com

RGNX stock outlook for YEAR - Inflation Watch & Real-Time Price Movement Reports  newser.com

RGNX stock outlook for YEAR - Inflation Watch & Real-Time Price Movement Reports - newser.com

Click here to get full coverage on Regenxbio Inc (RGNX) Q3 2025 Earnings Call Highlights: Strong Financial Position and Strategic ... - Yahoo Finance

Regenxbio Inc (RGNX) Q3 2025 Earnings Call Highlights: Strong Financial Position and Strategic ...  Yahoo Finance

Regenxbio Inc (RGNX) Q3 2025 Earnings Call Highlights: Strong Financial Position and Strategic ... - Yahoo Finance

Click here to get full coverage on Regenxbio (RGNX) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq

Regenxbio (RGNX) Reports Q3 Loss, Beats Revenue Estimates  Nasdaq

Regenxbio (RGNX) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq

Click here to get full coverage on REGENXBIO’s Late-Stage Pipeline Momentum Strengthens After Q3 Earnings Beat (NASDAQ:RGNX) - Seeking Alpha

REGENXBIO’s Late-Stage Pipeline Momentum Strengthens After Q3 Earnings Beat (NASDAQ:RGNX)  Seeking Alpha

REGENXBIO’s Late-Stage Pipeline Momentum Strengthens After Q3 Earnings Beat (NASDAQ:RGNX) - Seeking Alpha

Click here to get full coverage on REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights - PR Newswire

REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights  PR Newswire

REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights - PR Newswire

Click here to get full coverage on Real time social sentiment graph for RGNX - Global Markets & Accurate Trade Setup Notifications - newser.com

Real time social sentiment graph for RGNX - Global Markets & Accurate Trade Setup Notifications  newser.com

Real time social sentiment graph for RGNX - Global Markets & Accurate Trade Setup Notifications - newser.com

Click here to get full coverage on Earnings Update: REGENXBIO Inc. (NASDAQ:RGNX) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance

Earnings Update: REGENXBIO Inc. (NASDAQ:RGNX) Just Reported And Analysts Are Boosting Their Estimates  Yahoo Finance

Earnings Update: REGENXBIO Inc. (NASDAQ:RGNX) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance

Click here to get full coverage on What candlestick patterns are forming on RGNX - Fed Meeting & High Return Stock Watch Alerts - newser.com

What candlestick patterns are forming on RGNX - Fed Meeting & High Return Stock Watch Alerts  newser.com

What candlestick patterns are forming on RGNX - Fed Meeting & High Return Stock Watch Alerts - newser.com

Click here to get full coverage on REGENXBIO Inc. (RGNX): A Bull Case Theory - Yahoo Finance

REGENXBIO Inc. (RGNX): A Bull Case Theory  Yahoo Finance

REGENXBIO Inc. (RGNX): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on REGENXBIO Announces FDA Acceptance and Priority Review of the BLA for RGX-121 for MPS II - PR Newswire

REGENXBIO Announces FDA Acceptance and Priority Review of the BLA for RGX-121 for MPS II  PR Newswire

REGENXBIO Announces FDA Acceptance and Priority Review of the BLA for RGX-121 for MPS II - PR Newswire

Click here to get full coverage on Using RSI to spot recovery in RGNX - Weekly Trend Recap & AI Based Buy and Sell Signals - newser.com

Using RSI to spot recovery in RGNX - Weekly Trend Recap & AI Based Buy and Sell Signals  newser.com

Using RSI to spot recovery in RGNX - Weekly Trend Recap & AI Based Buy and Sell Signals - newser.com

Click here to get full coverage on REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights - PR Newswire

REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights  PR Newswire

REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights - PR Newswire

Click here to get full coverage on What machine learning models say about RGNX - 2025 Major Catalysts & High Yield Equity Trading Tips - newser.com

What machine learning models say about RGNX - 2025 Major Catalysts & High Yield Equity Trading Tips  newser.com

What machine learning models say about RGNX - 2025 Major Catalysts & High Yield Equity Trading Tips - newser.com

Click here to get full coverage on Using RSI to spot recovery in RGNX - Earnings Growth Summary & Verified Short-Term Plans - newser.com

Using RSI to spot recovery in RGNX - Earnings Growth Summary & Verified Short-Term Plans  newser.com

Using RSI to spot recovery in RGNX - Earnings Growth Summary & Verified Short-Term Plans - newser.com

Click here to get full coverage on What machine learning models say about RGNX - July 2025 Recap & Expert Approved Momentum Ideas - newser.com

What machine learning models say about RGNX - July 2025 Recap & Expert Approved Momentum Ideas  newser.com

What machine learning models say about RGNX - July 2025 Recap & Expert Approved Momentum Ideas - newser.com

Click here to get full coverage on Regression analysis insights on RGNX performance - 2025 Big Picture & Scalable Portfolio Growth Methods - newser.com

Regression analysis insights on RGNX performance - 2025 Big Picture & Scalable Portfolio Growth Methods  newser.com

Regression analysis insights on RGNX performance - 2025 Big Picture & Scalable Portfolio Growth Methods - newser.com

Click here to get full coverage on Using RSI to spot recovery in RGNX - Market Trend Report & Growth Focused Entry Reports - newser.com

Using RSI to spot recovery in RGNX - Market Trend Report & Growth Focused Entry Reports  newser.com

Using RSI to spot recovery in RGNX - Market Trend Report & Growth Focused Entry Reports - newser.com

Click here to get full coverage on What dividend safety score for RGNX stock - Weekly Trend Report & Proven Capital Preservation Tips - newser.com

What dividend safety score for RGNX stock - Weekly Trend Report & Proven Capital Preservation Tips  newser.com

What dividend safety score for RGNX stock - Weekly Trend Report & Proven Capital Preservation Tips - newser.com

Click here to get full coverage on Oct–Nov 2025: REGENXBIO to Present at Chardan, Guggenheim & Stifel Conferences; webcasts available for 30 days - Stock Titan

Oct–Nov 2025: REGENXBIO to Present at Chardan, Guggenheim & Stifel Conferences; webcasts available for 30 days  Stock Titan

Oct–Nov 2025: REGENXBIO to Present at Chardan, Guggenheim & Stifel Conferences; webcasts available for 30 days - Stock Titan

Click here to get full coverage on Will RGNX stock benefit from AI adoption - Analyst Upgrade & Growth Oriented Trading Recommendations - newser.com

Will RGNX stock benefit from AI adoption - Analyst Upgrade & Growth Oriented Trading Recommendations  newser.com

Will RGNX stock benefit from AI adoption - Analyst Upgrade & Growth Oriented Trading Recommendations - newser.com

Click here to get full coverage on What dividend safety score for RGNX stock - Day Trade & AI Enhanced Execution Alerts - newser.com

What dividend safety score for RGNX stock - Day Trade & AI Enhanced Execution Alerts  newser.com

What dividend safety score for RGNX stock - Day Trade & AI Enhanced Execution Alerts - newser.com

Click here to get full coverage on RBC Capital Maintains REGENXBIO (RGNX) Outperform Recommendation - Nasdaq

RBC Capital Maintains REGENXBIO (RGNX) Outperform Recommendation  Nasdaq

RBC Capital Maintains REGENXBIO (RGNX) Outperform Recommendation - Nasdaq

Click here to get full coverage on REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy - PR Newswire

REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy  PR Newswire

REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy - PR Newswire

Click here to get full coverage on New Analyst Forecast: $RGNX Given $34.0 Price Target - Quiver Quantitative

New Analyst Forecast: $RGNX Given $34.0 Price Target  Quiver Quantitative

New Analyst Forecast: $RGNX Given $34.0 Price Target - Quiver Quantitative

Click here to get full coverage on What machine learning models say about RGNX - Dividend Hike & High Accuracy Investment Signals - newser.com

What machine learning models say about RGNX - Dividend Hike & High Accuracy Investment Signals  newser.com

What machine learning models say about RGNX - Dividend Hike & High Accuracy Investment Signals - newser.com

Click here to get full coverage on RGNX stock outlook for YEAR - 2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com

RGNX stock outlook for YEAR - 2025 Fundamental Recap & Safe Investment Capital Preservation Plans  newser.com

RGNX stock outlook for YEAR - 2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com

Click here to get full coverage on REGENXBIO Inc. (RGNX) Q3 FY2025 earnings call transcript - Yahoo Finance

REGENXBIO Inc. (RGNX) Q3 FY2025 earnings call transcript  Yahoo Finance

REGENXBIO Inc. (RGNX) Q3 FY2025 earnings call transcript - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $RGNX Given $19.0 Price Target - Quiver Quantitative

New Analyst Forecast: $RGNX Given $19.0 Price Target  Quiver Quantitative

New Analyst Forecast: $RGNX Given $19.0 Price Target - Quiver Quantitative

Click here to get full coverage on $RGNX stock is down 8% today. Here's what we see in our data. - Quiver Quantitative

$RGNX stock is down 8% today. Here's what we see in our data.  Quiver Quantitative

$RGNX stock is down 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates  Yahoo Finance

Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on Using RSI to spot recovery in RGNX - Weekly Trade Review & Long-Term Safe Investment Plans - newser.com

Using RSI to spot recovery in RGNX - Weekly Trade Review & Long-Term Safe Investment Plans  newser.com

Using RSI to spot recovery in RGNX - Weekly Trade Review & Long-Term Safe Investment Plans - newser.com

Click here to get full coverage on REGENXBIO (NASDAQ: RGNX) to host third quarter results call Nov. 6 at 8:00 a.m. ET - Stock Titan

REGENXBIO (NASDAQ: RGNX) to host third quarter results call Nov. 6 at 8:00 a.m. ET  Stock Titan

REGENXBIO (NASDAQ: RGNX) to host third quarter results call Nov. 6 at 8:00 a.m. ET - Stock Titan

Click here to get full coverage on These Analysts Just Made An Incredible Downgrade To Their REGENXBIO Inc. (NASDAQ:RGNX) EPS Forecasts - Yahoo Finance

These Analysts Just Made An Incredible Downgrade To Their REGENXBIO Inc. (NASDAQ:RGNX) EPS Forecasts  Yahoo Finance

These Analysts Just Made An Incredible Downgrade To Their REGENXBIO Inc. (NASDAQ:RGNX) EPS Forecasts - Yahoo Finance

Click here to get full coverage on Real time social sentiment graph for RGNX - 2025 Top Gainers & Trade Opportunity Analysis - newser.com

Real time social sentiment graph for RGNX - 2025 Top Gainers & Trade Opportunity Analysis  newser.com

Real time social sentiment graph for RGNX - 2025 Top Gainers & Trade Opportunity Analysis - newser.com

Click here to get full coverage on REGENXBIO Inc. (NASDAQ:RGNX) is largely controlled by institutional shareholders who own 67% of the company - Yahoo Finance

REGENXBIO Inc. (NASDAQ:RGNX) is largely controlled by institutional shareholders who own 67% of the company  Yahoo Finance

REGENXBIO Inc. (NASDAQ:RGNX) is largely controlled by institutional shareholders who own 67% of the company - Yahoo Finance

Click here to get full coverage on 1,200+ Enrolled: REGENXBIO Completes Largest Gene Therapy Wet AMD Program; Topline Q4 2026 - Stock Titan

1,200+ Enrolled: REGENXBIO Completes Largest Gene Therapy Wet AMD Program; Topline Q4 2026  Stock Titan

1,200+ Enrolled: REGENXBIO Completes Largest Gene Therapy Wet AMD Program; Topline Q4 2026 - Stock Titan

Click here to get full coverage on How Regenxbio Inc. (RGNX) Affects Rotational Strategy Timing - news.stocktradersdaily.com

How Regenxbio Inc. (RGNX) Affects Rotational Strategy Timing  news.stocktradersdaily.com

How Regenxbio Inc. (RGNX) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Click here to get full coverage on What dividend safety score for RGNX stock - Buy Signal & Risk Controlled Stock Alerts - newser.com

What dividend safety score for RGNX stock - Buy Signal & Risk Controlled Stock Alerts  newser.com

What dividend safety score for RGNX stock - Buy Signal & Risk Controlled Stock Alerts - newser.com

Click here to get full coverage on $RGNX stock is up 12% today. Here's what we see in our data. - Quiver Quantitative

$RGNX stock is up 12% today. Here's what we see in our data.  Quiver Quantitative

$RGNX stock is up 12% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on REGENXBIO (NASDAQ: RGNX) completes RGX-202 enrollment of 30, starts commercial supply - Stock Titan

REGENXBIO (NASDAQ: RGNX) completes RGX-202 enrollment of 30, starts commercial supply  Stock Titan

REGENXBIO (NASDAQ: RGNX) completes RGX-202 enrollment of 30, starts commercial supply - Stock Titan

Click here to get full coverage on Using RSI to spot recovery in RGNX - July 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com

Using RSI to spot recovery in RGNX - July 2025 Pullbacks & Weekly High Conviction Trade Ideas  newser.com

Using RSI to spot recovery in RGNX - July 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com

Click here to get full coverage on First-Ever Gene Therapy for Hunter Syndrome: REGENXBIO's RGX-121 FDA Review Extended with New Data - Stock Titan

First-Ever Gene Therapy for Hunter Syndrome: REGENXBIO's RGX-121 FDA Review Extended with New Data  Stock Titan

First-Ever Gene Therapy for Hunter Syndrome: REGENXBIO's RGX-121 FDA Review Extended with New Data - Stock Titan

Click here to get full coverage on 2-Year Results: REGENXBIO Presents ALTITUDE Phase II Data for Diabetic Retinopathy Oct 17 - Stock Titan

2-Year Results: REGENXBIO Presents ALTITUDE Phase II Data for Diabetic Retinopathy Oct 17  Stock Titan

2-Year Results: REGENXBIO Presents ALTITUDE Phase II Data for Diabetic Retinopathy Oct 17 - Stock Titan

Click here to get full coverage on Regenxbio (RGNX) Projects Financial Stability into 2027 - GuruFocus

Regenxbio (RGNX) Projects Financial Stability into 2027  GuruFocus

Regenxbio (RGNX) Projects Financial Stability into 2027 - GuruFocus

Click here to get full coverage on What moving averages say about RGNX - Wall Street Watch & Technical Entry and Exit Alerts - newser.com

What moving averages say about RGNX - Wall Street Watch & Technical Entry and Exit Alerts  newser.com

What moving averages say about RGNX - Wall Street Watch & Technical Entry and Exit Alerts - newser.com

Click here to get full coverage on REGENXBIO Inc. (NASDAQ:RGNX) Held Back By Insufficient Growth Even After Shares Climb 29% - simplywall.st

REGENXBIO Inc. (NASDAQ:RGNX) Held Back By Insufficient Growth Even After Shares Climb 29%  simplywall.st

REGENXBIO Inc. (NASDAQ:RGNX) Held Back By Insufficient Growth Even After Shares Climb 29% - simplywall.st

Click here to get full coverage on Regenxbio: Q3 Earnings Snapshot - New Haven Register

Regenxbio: Q3 Earnings Snapshot  New Haven Register

Regenxbio: Q3 Earnings Snapshot - New Haven Register

Click here to get full coverage on RGNX: RBC Capital Raises Price Target to $19, Maintains Outperfo - GuruFocus

RGNX: RBC Capital Raises Price Target to $19, Maintains Outperfo  GuruFocus

RGNX: RBC Capital Raises Price Target to $19, Maintains Outperfo - GuruFocus

Click here to get full coverage on What moving averages say about RGNX - Market Performance Summary & Verified Momentum Stock Alerts - newser.com

What moving averages say about RGNX - Market Performance Summary & Verified Momentum Stock Alerts  newser.com

What moving averages say about RGNX - Market Performance Summary & Verified Momentum Stock Alerts - newser.com

Click here to get full coverage on Will RGNX stock benefit from AI adoption - Profit Target & Accurate Intraday Trading Signals - newser.com

Will RGNX stock benefit from AI adoption - Profit Target & Accurate Intraday Trading Signals  newser.com

Will RGNX stock benefit from AI adoption - Profit Target & Accurate Intraday Trading Signals - newser.com

Click here to get full coverage on What dividend safety score for RGNX stock - Weekly Trend Summary & Weekly High Return Stock Opportunities - newser.com

What dividend safety score for RGNX stock - Weekly Trend Summary & Weekly High Return Stock Opportunities  newser.com

What dividend safety score for RGNX stock - Weekly Trend Summary & Weekly High Return Stock Opportunities - newser.com

Click here to get full coverage on REGENXBIO (RGNX) Exceeds Q3 Revenue Expectations with Strong Gen - GuruFocus

REGENXBIO (RGNX) Exceeds Q3 Revenue Expectations with Strong Gen  GuruFocus

REGENXBIO (RGNX) Exceeds Q3 Revenue Expectations with Strong Gen - GuruFocus

Click here to get full coverage on What earnings revisions data tells us about RGNX - Analyst Downgrade & Risk Managed Investment Signals - newser.com

What earnings revisions data tells us about RGNX - Analyst Downgrade & Risk Managed Investment Signals  newser.com

What earnings revisions data tells us about RGNX - Analyst Downgrade & Risk Managed Investment Signals - newser.com

Click here to get full coverage on H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $34 - 富途牛牛

H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $34  富途牛牛

H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $34 - 富途牛牛

Click here to get full coverage on Insider Sale: Chief Executive Officer of $RGNX Sells 20,811 Shares | RGNX Stock News - Quiver Quantitative

Insider Sale: Chief Executive Officer of $RGNX Sells 20,811 Shares | RGNX Stock News  Quiver Quantitative

Insider Sale: Chief Executive Officer of $RGNX Sells 20,811 Shares | RGNX Stock News - Quiver Quantitative

Click here to get full coverage on Regenxbio Inc (RGNX) Q3 2025 Earnings: EPS Loss of $1.20 Beats E - GuruFocus

Regenxbio Inc (RGNX) Q3 2025 Earnings: EPS Loss of $1.20 Beats E  GuruFocus

Regenxbio Inc (RGNX) Q3 2025 Earnings: EPS Loss of $1.20 Beats E - GuruFocus

Click here to get full coverage on RegenXBio (RGNX) Gets a Buy from Bank of America Securities - The Globe and Mail

RegenXBio (RGNX) Gets a Buy from Bank of America Securities  The Globe and Mail

RegenXBio (RGNX) Gets a Buy from Bank of America Securities - The Globe and Mail

Click here to get full coverage on How RGNX stock performs in rate cut cycles - July 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com

How RGNX stock performs in rate cut cycles - July 2025 Outlook & AI Powered Trade Plan Recommendations  newser.com

How RGNX stock performs in rate cut cycles - July 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com

Click here to get full coverage on Barclays Sticks to Their Buy Rating for RegenXBio (RGNX) - The Globe and Mail

Barclays Sticks to Their Buy Rating for RegenXBio (RGNX)  The Globe and Mail

Barclays Sticks to Their Buy Rating for RegenXBio (RGNX) - The Globe and Mail

Click here to get full coverage on Is REGENXBIO (NASDAQ:RGNX) A Risky Investment? - simplywall.st

Is REGENXBIO (NASDAQ:RGNX) A Risky Investment?  simplywall.st

Is REGENXBIO (NASDAQ:RGNX) A Risky Investment? - simplywall.st

Click here to get full coverage on Regenxbio (RGNX) CEO Simpson Curran sells $76k in shares - Investing.com

Regenxbio (RGNX) CEO Simpson Curran sells $76k in shares  Investing.com

Regenxbio (RGNX) CEO Simpson Curran sells $76k in shares - Investing.com

Click here to get full coverage on Multi asset correlation models including RGNX - July 2025 Market Mood & High Accuracy Trade Signal Alerts - newser.com

Multi asset correlation models including RGNX - July 2025 Market Mood & High Accuracy Trade Signal Alerts  newser.com

Multi asset correlation models including RGNX - July 2025 Market Mood & High Accuracy Trade Signal Alerts - newser.com

Click here to get full coverage on Regenxbio: Q3 Earnings Snapshot - CT Insider

Regenxbio: Q3 Earnings Snapshot  CT Insider

Regenxbio: Q3 Earnings Snapshot - CT Insider

Click here to get full coverage on Real time social sentiment graph for RGNX - Portfolio Growth Summary & High Accuracy Buy Signal Tips - newser.com

Real time social sentiment graph for RGNX - Portfolio Growth Summary & High Accuracy Buy Signal Tips  newser.com

Real time social sentiment graph for RGNX - Portfolio Growth Summary & High Accuracy Buy Signal Tips - newser.com

Click here to get full coverage on REGENXBIO to Participate in Upcoming Investor Conferences - Stock Titan

REGENXBIO to Participate in Upcoming Investor Conferences  Stock Titan

RGNX

Price Chart

Key Statistics

Technicals

About RGNX

Latest News

REGENXBIO Announces Presentation at the World Muscle Society - PR Newswire

What dividend safety score for RGNX stock - New Guidance & Consistent Income Trade Recommendations - Fundação Cultural do Pará

RGNX stock outlook for YEAR - Inflation Watch & Real-Time Price Movement Reports - newser.com

Advanced Charts

Top Gainers

Top Losers